Review: A Safety Profile of Dalbavancin for On- and Off-Label Utilization
Oriana Simonetti,1,* Giulio Rizzetto,1,* Elisa Molinelli,1 Oscar Cirioni,2 Annamaria Offidani1 1Clinic of Dermatology, Department of Clinical and Molecular Sciences, Polytechnic University of Marche, Ancona, Italy; 2Clinic of Infectious Diseases, Department of Biomedical Sciences and Public Health,...
Guardado en:
Autores principales: | Simonetti O, Rizzetto G, Molinelli E, Cirioni O, Offidani A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ce1a843304f24890add6b3d7d6345f8c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
New Perspectives on Old and New Therapies of Staphylococcal Skin Infections: The Role of Biofilm Targeting in Wound Healing
por: Oriana Simonetti, et al.
Publicado: (2021) -
Comparative Analysis of Dalbavancin versus Other Antimicrobial Options for Gram-Positive Cocci Infections: Effectiveness, Hospital Stay and Mortality
por: Mar de Pablo-Miró, et al.
Publicado: (2021) -
Safety and efficacy of tocilizumab for rheumatoid arthritis: a systematic review and metaanalysis of clinical trial studies
por: Amal Saki, et al.
Publicado: (2021) -
Patient-Reported Questionnaires to Identify Adverse Drug Reactions: A Systematic Review
por: Renly Lim, et al.
Publicado: (2021) -
Safety findings from CENTURION, a phase 3 consistency study of lasmiditan for the acute treatment of migraine
por: C Tassorelli, et al.
Publicado: (2021)